Bristol Myers Squibb Expands AI Collaboration with NVIDIA
PRINCETON, N.J., July 20, 2026 Bristol Myers Squibb (BMS) announced a major expansion of its strategic collaboration with NVIDIA...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
PRINCETON, N.J., July 20, 2026 Bristol Myers Squibb (BMS) announced a major expansion of its strategic collaboration with NVIDIA...
Boston, Massachusetts, March 16, 2026 Manifold Bio, a platform therapeutics company focused on AI-driven drug discovery, announced breakthrough results...
SAN FRANCISCO, January 12, 2026 — NVIDIA and Eli Lilly and Company announced the creation of a first-of-its-kind AI...
